Camolesi GCV, Ortega KL, Medina JB, Campos L, Lorenzo Pouso AI, Gándara Vila P, et al. Therapeutic alternatives in the management of osteoradionecrosis of the jaws. Systematic review. Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26 (2):e195-207.
doi:10.4317/medoral.24132
https://dx.doi.org/doi:10.4317/medoral.24132
1. Ray-Chaudhuri A, Shah K, Porter RJ. The oral management of patients who have received radiotherapy to the head and neck region. Br Dent J. 2013;214:387-93. |
PMid:23619856 |
2. Abed H, Reilly D, Burke M, Daly B. Patients with head and neck cancers' oral health knowledge, oral health-related quality of life, oral health status, and adherence to advice on discharge to primary dental care: A prospective observational study. Observational Study. 2019;39:593-602. |
PMid:31490570 |
3. Kim BJ, Kang HG, Lee SW, Jung J, Lee MH, Kang DW, et al. Changes in the Common Carotid Artery after Radiotherapy: Wall Thickness, Calcification, and Atherosclerosis. J Clin Neurol. 2018;14:35-42. |
PMid:29629538 PMCid:PMC5765254 |
4. Murthy V, Gupta T, Kadam A, Ghosh-Laskar S, Budrukkar A, Phurailatpam R, et al. Time trial: A prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers. J Cancer Res Ther. 2009;5:107-12. |
PMid:19542666 |
5. Clark CH, Miles EA, Urbano MTG, Bhide SA, Bidmead AM, Harrington KJ, et al. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br J Radiol. 2009 Jul;82:585-94. |
PMid:19332518 |
6. Nabil S, Ramli R. The use of buccal fat pad flap in the treatment of osteoradionecrosis. Int J Oral Maxillofac Surg. 2012;41:1422-6. |
PMid:22560870 |
7. D'Souza J, Lowe D, Rogers SN. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: Experience from a regional head and neck unit. Br J Oral Maxillofac Surg. 2014;52:356-62. |
PMid:24480621 |
8. Lyons AJ, West CM, Risk JM, Slevin NJ, Chan C, Crichton S, et al. Osteoradionecrosis in Head-and-Neck Cancer Has a Distinct Genotype-Dependent Cause. Int J Radiat Oncol. 2012;82:1479-84. |
PMid:21708430 |
9. Marx RE. Osteoradionecrosis: A new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283-8. |
PMid:6572704 |
10. Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg. 1987;45:104-10. |
PMid:3468211 |
11. Mainous EG. Hyperbaric oxygen in total rehabilitation of patients with mandibular osteoradionecrosis. Int J Oral Surg. 1974;3:297-301. |
PMid:4214292 |
12. Santamaria E, Wei FC, Chen HC. Fibula osteoseptocutaneous flap for reconstruction of osteoradionecrosis of the mandible. Plast Reconstr Surg. 1998;101:921-9. |
PMid:9514323 |
13. Ang E, Black C, Irish J, Brown DH, Gullane P, O'Sullivan B, et al. Reconstructive options in the treatment of osteoradionecrosis of the craniomaxillofacial skeleton. Br J Plast Surg. 2003;56:92-9. |
PMid:12791349 |
14. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379-90. |
PMid:3477756 |
15. London SD, Park SS, Gampper TJ, Hoard MA. Hyperbaric oxygen for the management of radionecrosis of bone and cartilage. Laryngoscope. 1998;108:1291-6. |
PMid:9738743 |
16. Lyons A, Osher J, Warner E, Kumar R, Brennan PA. Osteoradionecrosis-A review of current concepts in defining the extent of the disease and a new classification proposal. Br J Oral Maxillofac Surg. 2014;52:392-5. |
PMid:24725905 |
17. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck. 2001;23:389-98. |
PMid:11295813 |
18. Shaw RJ, Butterworth C. Hyperbaric oxygen in the management of late radiation injury to the head and neck. Part II: prevention. Br J Oral Maxillofac Surg. 2011;49:9-13. |
PMid:20347190 |
19. McLeod NMH, Bater MC, Brennan PA. Management of patients at risk of osteoradionecrosis: results of survey of dentists and oral & maxillofacial surgery units in the United Kingdom, and suggestions for best practice. Br J Oral Maxillofac Surg. 2010;48:301-4. |
PMid:19660845 |
20. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119-31. |
PMid:15542158 |
21. Patel V, Ormondroyd L, Lyons A, McGurk M. The financial burden for the surgical management of osteoradionecrosis. Br Dent J. 2017;222:177-80. |
PMid:28184080 |
22. Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: A phase II trial. Head Neck. 2005;27:114-23. |
PMid:15641107 |
23. Cha YH, Hong N, Rhee Y, Cha IH. Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw. Osteoporos Int. 2018;29:987-92. |
PMid:29249017 |
24. Ribeiro GH, Minamisako MC, Rath IBD, Santos AMB, Simoes A, Pereira KCR, et al. Osteoradionecrosis of the jaws: case series treated with adjuvant low-level laser therapy and antimicrobial photodynamic therapy. J Appl Oral Sci. 2018;26:e20170172. |
PMid:29791570 |
25. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. |
PMid:19621070 PMCid:PMC2707010 |
26. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5. |
PMid:20652370 |
27. Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv wound care. 2015;4:560-82. |
PMid:26339534 PMCid:PMC4528992 |
28. Chronopoulos A, Zarra T, Tröltzsch M, Mahaini S, Ehrenfeld M, Otto S. Osteoradionecrosis of the mandible: A ten year single-center retrospective study. J Cranio-Maxillofacial Surg. 2015;43:837-46. |
PMid:25939311 |
29. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, et al. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017;22:343-50. |
PMid:28209748 PMCid:PMC5344641 |
30. Jacobson AS, Buchbinder D, Urken ML. Reconstruction of bilateral osteoradionecrosis of the mandible using a single fibular free flap. Laryngoscope. 2010;120:273-5. |
PMid:19950382 |
31. Danielsson D, Munck-Wikland E, Hagel E, Halle M. Quality of life after microvascular mandibular reconstruction for osteoradionecrosis-A prospective study. Head Neck. 2019;41:2225-30. |
PMid:30721560 |
32. Mucke T, Koschinski J, Rau A, Loeffelbein DJ, Deppe H, Mitchell DA, et al. Surgical outcome and prognostic factors after treatment of osteoradionecrosis of the jaws. J Cancer Res Clin Oncol. 2013;139:389-94. |
PMid:23108891 |
33. Chang DW, Oh HK, Robb GL, Miller MJ. Management of advanced mandibular osteoradionecrosis with free flap reconstruction. Head Neck. 2001;23:830-5. |
PMid:11592229 |
34. Woo SH. Buccinator Myomucosal Flap for Treatment of Osteoradionecrosis of the Mandible. Clin Exp Otorhinolaryngol. 2016;9:85-8. |
PMid:26976033 PMCid:PMC4792249 |
35. Etezadi A, Ferguson H, Emam HA, Walker P. Multiple Remediation of Soft Tissue Reconstruction in Osteoradionecrosis of the Mandible: A Case Report. J Oral Maxillofac Surg. 2013;71:e1-6. |
PMid:23245773 |
36. Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): A phase II trial. Int J Radiat Oncol Biol Phys. 2011;80:832-9. |
PMid:20638190 |
37. Batstone MD, Cosson J, Marquart L, Acton C. Platelet rich plasma for the prevention of osteoradionecrosis. A double blinded randomized cross over controlled trial. Int J Oral Maxillofac Surg. 2012;41:2-4. |
PMid:21782389 |
38. Gallesio G, Del Fabbro M, Pol R, Mortellaro C, Mozzati M. Conservative treatment with plasma rich in growth factors-Endoret for osteoradionecrosis. J Craniofac Surg. 2015;26:731-6. |
PMid:25974781 |
39. Andrews EB, Gilsenan A, Midkiff K, Harris D. Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma. Ann Epidemiol. 2016;26:751-3. |
PMid:27645108 |
40. Woodruff LD, Bounkeo JM, Brannon WM, Dawes KS, Barham CD, Waddell DL, et al. The efficacy of laser therapy in wound repair: a meta-analysis of the literature. Photomed Laser Surg. 2004;22:241-7. |
PMid:15315732 |